WHO Technical Advisory Group of Experts on Diabetes (TAG-D)
TAG-D provides technical advice to WHO on matters relating to WHO's work on diabetes.
The WHO Global Diabetes Compact
WHO / Atul Loke
©
Credits
The vision
Responding to the increasing burden of diabetes around the world, the World Health Organization has launched the Global Diabetes Compact. The launch coincides with the 100th anniversary of the discovery of insulin.
The WHO Global Diabetes Compact has the vision of reducing the risk of diabetes, and ensuring that all people who are diagnosed with diabetes have access to equitable, comprehensive, affordable and quality treatment and care. The work undertaken as part of the Compact will also support the prevention of type 2 diabetes from obesity, unhealthy diet and physical inactivity.
Engagement
Engagement structure
Contact
Campaigns
14 November is World Diabetes Day
Breaking barriers, bridging gaps
Videos
Technical resources
24 January 2025
Operational handbook on tuberculosis: module 6: tuberculosis and comorbidities, 3rd ed
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy....
18 November 2024
The Global Diabetes Compact: progress in supporting its workstreams: technical report
In 2021, WHO launched the Global Diabetes Compact (GDC), an initiative to reduce the risk of diabetes and ensure that all people who are diagnosed with...
14 November 2024
Guidance on global monitoring for diabetes prevention and control: Framework, indicators and application
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing...
28 March 2024
Thermostability of human insulin
Diabetes is an escalating global health crisis that is expected to impact 1.3 billion people by 2050. Diabetes prevalence is predicted to increase even...
10 November 2023
Tobacco and diabetes
This document is the seventh in a series of Tobacco Knowledge Summaries. This document is prepared with the objective to summarize the current evidence...
18 October 2023
The selection and use of essential in vitro diagnostics: report of the fourth meeting of the WHO Strategic...
The Technical report of the fourth meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2022 (including the fourth WHO model...
3 July 2023
WHO acceleration plan to stop obesity
At the 75th World Health Assembly in 2022, Member States adopted new recommendations for the prevention and management of obesity and endorsed the...
7 September 2020
WHO package of essential noncommunicable (PEN) disease interventions for primary health care
Noncommunicable diseases (NCDs), also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological,...
22 April 2020
HEARTS D: diagnosis and management of type 2 diabetes
This new HEARTS – D module on Diagnosis and management of type 2 diabetes complements and expands the diabetes section of the HEARTS Technical Package...
21 April 2018
Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels...
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular...
27 December 2016
HEARTS: Technical package for cardiovascular disease management in primary health care
High blood pressure kills more people than any other condition – approximately 10 million people each year, more than all infectious diseases combined....
Other technical resources
